EcoDrugPlus

Sodium/hydrogen Exchanger 3

Ensembl ID : ENSMZEG00005026255
Gene Symbol: LOC101473782
3 Cross references
222 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-1

Ensembl ID : ENSMZEG00005017626
Gene Symbol: LOC101477629
2 Cross references
198 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-1

Ensembl ID : ENSMZEG00005017609
Gene Symbol: LOC101477348
2 Cross references
169 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-1

Ensembl ID : ENSMZEG00005017594
Gene Symbol: LOC101477070
2 Cross references
169 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-1

Ensembl ID : ENSMZEG00005017639
Gene Symbol: LOC101476791
2 Cross references
198 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-2

Ensembl ID : ENSMZEG00005024097
Gene Symbol: LOC101481172
3 Cross references
205 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-2

Ensembl ID : ENSMZEG00005016162
Gene Symbol: LOC101485486
3 Cross references
203 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-2

Ensembl ID : ENSMZEG00005009227
Gene Symbol: LOC101476439
3 Cross references
196 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-233

Ensembl ID : ENSMZEG00005019152
Gene Symbol: LOC101473367
3 Cross references
220 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-3

Ensembl ID : ENSMZEG00005005221
Gene Symbol: LOC101484391
3 Cross references
236 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-3

Ensembl ID : ENSMZEG00005002653
Gene Symbol: LOC101482597
3 Cross references
232 Possible Orthologues:

Solute Carrier Family 18 Member A2

Ensembl ID : ENSMZEG00005005147
Gene Symbol: SLC18A2
3 Cross references
216 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).